---
format:
  revealjs: 
    slide-number: true
    chalkboard: 
      buttons: false
    preview-links: auto
    logo: files/images/uoo.png
    theme: white
    css: files/styles.css
    footer: "Confirmation of Status"
    smaller: false
    auto-stretch: false
    mouse-wheel: false
    history: true
    touch: true
    link-external-icon: false
    link-external-newwindow: true
    link-external-filter: ^\/Users\/custom
bibliography: files/refs.bib
csl: files/elsevier-harvard.csl
link-citations: true
link-bibliography: true
editor: source
---

## [Elective, aseptic revision knee arthroplasty:]{style="color: #EE7520;"} {.smaller background-color="#0F1D41"}

```{=html}
<br>
<h1 style="text-align:center;">Measuring outcomes, patient perspectives and cost-effectiveness</h1>
<br>
<br>
<p style="text-align:center; color:#01A2DE;">Shiraz A. Sabah</p>
```

::: {.footer}
:::

## Conflicts of interest

None

## Funder statement {.smaller}

::: columns
::: {.column width="45%"}
This programme of research was supported by:

- NIHR Doctoral Research Fellowship (NIHR301771)
- Royal College of Surgeons One Year Fellowship
- Rosetrees Trust

The views expressed are those of the authors and not necessarily those of the funders.
:::

::: {.column width="10%"}
:::

::: {.column width="45%"}
:::{r-stack}
![](files/images/nihr.png){width="500"}
![](files/images/rcs.png){width="350"}
![](files/images/rosetrees.png){width="500"}
:::
:::
:::

# Introduction {background-color="#0F1D41"}

## Primary knee arthroplasty (pKA)

::: columns
::: {.column width="55%"}
- 100,000 pKA/yr in UK
- 10-15% patients -> chronic pain
- 4% pKA revised within 10 years
:::

::: {.column width="10%"}
:::

::: {.column width="35%"}
:::{r-stack}
![](files/images/knee xr.png){width="400"}
:::
:::
:::

## Revision knee arthroplasty (rKA)

- Heterogenous group
  - Minor & major surgery
  - Predictable & unpredictable clinical outcomes

## Urgent v elective indications

::: columns

::: {.column width="49%"}
:::{.callout-important collapse=true appearance='default' icon=true}
## URGENT (25%)
- High rate of early mortality [@abram2021]
  - PJI ~ 2%
  - Fracture ~ 5%
    
- Serious adverse events common [@boddapati2018; @abram2021]
    
- Expensive [@kallala2015a]
:::
:::

::: {.column width="2%"}
:::

::: {.column width="49%"}
:::{.callout-note collapse=true appearance='default' icon=true}
## ELECTIVE (75%)
- Similar to pKA?
:::
:::
:::

## Variability in PROMs for elective, aseptic rKA

:::{r-stack}
![](files/images/baker-rfr.png){height="400" fig-align="center"}
:::

::: {.aside}
[@baker2012b]
:::

## Patient and Public Involvement {auto-animate="true"}

::: columns
::: {.column width="60%"}
<br>
<q>How should we measure the outcomes following revision knee surgery in a way that is meaningful to patients and is surgery cost effective?</q>
:::

::: {.column width="5%"}
:::

::: {.column width="35%"}
:::{r-stack}
![](files/images/jla.png)
:::
:::
:::

::: {.aside}
[@mathews2020]
:::

<!-- ## Gaps in the evidence  {auto-animate="true" .smaller .hidden} -->

<!-- ::: {.incremental} -->
<!-- -	How common is elective, aseptic rKA? What are the trends in the rate of intervention over time? Have the indications for surgery changed? -->
<!-- -	How should we measure the outcome from surgery in a way that is meaningful to patients? Can we use existing PROMs? -->
<!-- - What are the risks and benefits of elective, aseptic rKA? Does the outcome from surgery depend on the diagnosis? -->
<!-- - Are there patient groups who experience variable or poor outcomes from elective, aseptic rKA? What underpins the decision to operate in these cases? Are these procedures cost-effective?  -->
<!-- ::: -->


## Aims {.smaller}

This thesis aims to improve the management of patients undergoing elective, aseptic rKA by advancing our knowledge on:

::: {.incremental}
- Epidemiology of elective, aseptic rKA;
- Validity of existing instruments to measure the outcome following surgery;
- Patient-relevant outcomes from surgery;
- Surgical decision making - from the perspective of patients, surgeons and the healthcare system
:::

## Objectives {.smaller}

This thesis will deliver the following objectives:

::: {.incremental}
-	An epidemiological study to investigate the rate and indications for elective, aseptic rKA and trends over time ([Chapter 3](#c3))
-	A systematic review of current use and measurement properties of existing patient reported outcome measures (PROMs) for elective, aseptic rKA ([Chapter 4](#c4))
- A systematic review of patient-relevant outcomes following rKA ([Chapter 5](#c5))
- A registry study of patient-relevant outcomes following rKA by diagnosis ([Chapter 6](#c6))
-	A qualitative interview study to explore the decision to operate for unexplained pain ([Chapter 7](#c7))
-	A health economic evaluation of rKA versus non-operative management for the management of unexplained pain ([Chapter 8](#c8))
:::

# Epidemiology of rKA {background-color="#0F1D41" #c3}

Chapter 3

## Methods

- Aim:
  - To investigate the rate of intervention for elective, aseptic rKA in the UK and trends over time.
- Design: 
  - Cross-sectional study; 2006 - 2020
- Datasets: 
  - National Joint Registry (NJR)
  - Office for National Statistics

::: {.footer}
Chapter 3: Epidemiology
:::

## Increases in rate of rKA have slowed

:::{r-stack}
![](files/images/epi-time.png){height="500" fig-align="center"}
:::

::: {.footer}
Chapter 3: Epidemiology
:::

## Indications for rKA have changed

:::{r-stack}
![](files/images/epi-rfr.png){height="500" fig-align="center"}
:::

::: {.footer}
Chapter 3: Epidemiology
:::

# Validity of PROM instruments {background-color="#0F1D41" #c4}

Chapter 4

::: {.footer}
Chapter 4: PROMs
:::

## Methods

- Aim:
    - To investigate measurement properties of existing PROMs for joint function in elective, aseptic rKA.

-	Design:
    - Systematic review (following the COSMIN checklist)

::: {.footer}
Chapter 4: PROMs
:::

## PROMs increasingly used; evidence for validity insufficient

```{=html}
<iframe src="files/papers/rka_cosmin.pdf" style="border: 3px solid #dee2e6;" width="1000" height="550"></iframe>
```

[@sabah2021e]

::: {.footer}
Chapter 4: PROMs
:::

## Measurement properties of Oxford Knee Score (OKS)

- Aim:
    - To investigate the measurement properties of the OKS (since no validation study was found in the systematic review, yet the instrument is widely used for rKA)

-	Design:
    - Psychometric study (using the NHS PROMs dataset)

## OKS had good measurement properties for elective, aseptic rKA

```{=html}
<iframe src="files/papers/rka_oks_val.pdf" style="border: 3px solid #dee2e6;" width="1000" height="550"></iframe>
```

[@sabah2021]

::: {.footer}
Chapter 4: PROMs
:::

# Systematic review of patient-relevant outcomes {background-color="#0F1D41" #c5}

Chapter 5

::: {.footer}
Chapter 5: Systematic review
:::

## Methods

- Aim:
    - To critically summarise patient-relevant outcomes following elective, aseptic rKA compared to non-operative management:
        - Implant survivorship
        - Mortality
        - Serious medical complications
        - Patient-reported outcome measures (PROMs)
        - Length of index hospital admission

::: {.footer}
Chapter 5: Systematic review
:::

## Study design

:::{r-stack}
![](files/images/sr-design.png){height="550" fig-align="center"}
:::

::: {.footer}
Chapter 5: Systematic review
:::

## PRISMA flowchart

:::{r-stack}
![](files/images/sr-prisma.png){height="550" fig-align="center"}
:::

::: {.footer}
Chapter 5: Systematic review
:::

## Implant survivorship

:::{r-stack}
![](files/images/sr-is.jpg){height="550" fig-align="center"}
:::

::: {.footer}
Chapter 5: Systematic review
:::


## Other findings

```{=html}
<iframe src="files/papers/05-sr.pdf" style="border: 3px solid #dee2e6;" width="1000" height="500"></iframe>
```

::: {.footer}
Chapter 5: Systematic review
:::

## Conclusions

- No randomised controlled trials or comparative studies of elective, aseptic rKA compared to non-operative management. 
- Insufficient evidence to stratify patient relevant outcomes by diagnosis - justifying the need for [Chapter 6](#c6).

::: {.footer}
Chapter 5: Systematic review
:::


# Patient-relevant outcomes by diagnosis {background-color="#0F1D41" #c6}

Chapter 6

::: {.footer}
Chapter 6: Big data
:::

## Methods

- Aim:
    - To investigate patient-relevant outcomes by diagnosis using the latest available national data.

-	Design:
    - Retrospective cohort study
    - Data from: NJR, HES, NHS PROMs, and Civil Registrations (Mortality)
    
::: {.footer}
Chapter 6: Big data
:::


## Data linkage

:::{r-stack}
![](files/images/bd-flow.png){height="550" fig-align="center"}
:::

::: {.footer}
Chapter 6: Big data
:::

## Patient-relevant outcomes from rKA by diagnosis 

[https://shiraz-sabah.shinyapps.io/rKA-app/](https://shiraz-sabah.shinyapps.io/rKA-app/)

::: {.footer}
:::

# Decision to operate for unexplained pain {background-color="#0F1D41" #c7}

Chapter 7

::: {.footer}
Chapter 7: Qualitative
:::

## Methods {.smaller}

- Aim:
    - To understand the decision to operate for unexplained, chronic pain
    
- Design:
    - Qualitative interview study
    - Thematic analysis as per Braun & Clarke
    
- Progress:
    - Surgeon interviews near completion;
    - Patient recruitment underway
    
::: {.footer}
Chapter 7: Qualitative
:::

# Cost-effectiveness analysis of rKA for unexplained pain {background-color="#0F1D41" #c8}

Chapter 8

::: {.footer}
Chapter 8: HEE
:::

## Methods {.smaller}

- Aim:
    - To investigate the cost-effectiveness of rKA compared to non-operative management for the treatment of unexplained, chronic pain after KA
    
- Design:
    - A patient-level simulation of rKA versus non-operative management using data from national secondary care datasets and other sources
    
- Progress:
    - HEAP design
    
::: {.footer}
Chapter 8: HEE
:::


# Future work {background-color="#0F1D41"}

::: {.footer}
Future work
:::

## Gantt chart

:::{r-stack}
![](files/images/conf-gantt.svg){height="600" fig-align="center"}
:::

::: {.footer}
Future work
:::

# Conclusion {.smaller}

This DPhil has started to create useful information on:

  - Epidemiology of rKA
  - Validity of existing PROMs
  - Patient-relevant outcomes following surgery

The remaining chapters will investigate patients with unexplained pain:

  - Understanding the decision to operate
  - Cost-effectiveness of surgery

# Thank you
<br>
[shiraz.sabah@ndorms.ox.ac.uk](mailto:shiraz.sabah@ndorms.ox.ac.uk)

# References {.smaller .scrollable}
::: {#refs}
:::